To this end, the combination of CPT‐Low or suboptimal dose of anti‐PD‐1 antibody (5 mg kg−1) was tested in colon adenocarcinoma MC38 mouse syngeneic tumor models. This evidence concerns the gene PDCD1 and colon adenocarcinoma.